These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3136156)

  • 61. Agonist and antagonist properties of calmodulin fragments.
    Newton DL; Oldewurtel MD; Krinks MH; Shiloach J; Klee CB
    J Biol Chem; 1984 Apr; 259(7):4419-26. PubMed ID: 6323472
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Apocalmodulin and Ca2+ calmodulin bind to the same region on the skeletal muscle Ca2+ release channel.
    Moore CP; Rodney G; Zhang JZ; Santacruz-Toloza L; Strasburg G; Hamilton SL
    Biochemistry; 1999 Jun; 38(26):8532-7. PubMed ID: 10387100
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inhibition of protein A24 lyase by nitrosoureas.
    Markussen G; Smith-Kielland I; Dornish JM
    FEBS Lett; 1984 Oct; 176(2):426-30. PubMed ID: 6489526
    [TBL] [Abstract][Full Text] [Related]  

  • 64. N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea sensitivity in mismatch repair-defective human cells.
    Aquilina G; Ceccotti S; Martinelli S; Hampson R; Bignami M
    Cancer Res; 1998 Jan; 58(1):135-41. PubMed ID: 9426069
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prolonged depression of hepatic microsomal drug metabolism and hemoprotein levels following a single dose of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU).
    Litterst CL
    Biochem Pharmacol; 1981 May; 30(9):1014-6. PubMed ID: 7236311
    [No Abstract]   [Full Text] [Related]  

  • 66. Limited digestion of calmodulin with trypsin in the presence or absence of various metal ions.
    Kawasaki H; Kurosu Y; Kasai H; Isobe T; Okuyama T
    J Biochem; 1986 May; 99(5):1409-16. PubMed ID: 3711069
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reproduction and teratological studies with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in the rat and rabbit.
    Thompson DJ; Molello JA; Strebing RJ; Dyke IL
    Toxicol Appl Pharmacol; 1975 Dec; 34(3):456-66. PubMed ID: 1209639
    [No Abstract]   [Full Text] [Related]  

  • 68. Determination of the side chain pKa values of the lysine residues in calmodulin.
    Zhang M; Vogel HJ
    J Biol Chem; 1993 Oct; 268(30):22420-8. PubMed ID: 8226750
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Calcium-induced sensitization of the central helix of calmodulin to proteolysis.
    Mackall J; Klee CB
    Biochemistry; 1991 Jul; 30(29):7242-7. PubMed ID: 1854733
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Combination chemotherapy of transplanted rat leukemia L 5222 with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and cyclophosphamide (CPA) as well as with methyl-CCNU and CPA (author's transl)].
    Zeller WJ; Berger M
    Arzneimittelforschung; 1981; 31(2):303-5. PubMed ID: 7194646
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Protein kinase C inhibition by calmodulin and its fragments.
    Krüger H; Schröder W; Buchner K; Hucho F
    J Protein Chem; 1990 Aug; 9(4):467-73. PubMed ID: 2275756
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Spin labeled antioxidants protect bacteria against the toxicity of alkylating antitumor drug CCNU.
    Gadjeva V; Lazarova G; Zheleva A
    Toxicol Lett; 2003 Oct; 144(3):289-94. PubMed ID: 12927347
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.
    Lee FY; Workman P
    Br J Cancer; 1983 May; 47(5):659-69. PubMed ID: 6849803
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Regulation of brain cyclic nucleotide phosphodiesterase by calmodulin. A quantitative analysis.
    Cox JA; Malnoë A; Stein EA
    J Biol Chem; 1981 Apr; 256(7):3218-22. PubMed ID: 6259154
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Relationship of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) pharmacokinetics of uptake, distribution, and tissue/plasma partitioning in rat organs and intracerebral tumors.
    Levin VA; Kabra PA; Freeman-Dove MA
    Cancer Chemother Pharmacol; 1978; 1(4):233-42. PubMed ID: 750110
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Phosphorylation and characterization of bovine heart calmodulin-dependent phosphodiesterase.
    Sharma RK
    Biochemistry; 1991 Jun; 30(24):5963-8. PubMed ID: 1646004
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Properties of a cyclic nucleotide phosphodiesterase of amphibian oocytes that is activated by calmodulin and calcium, by tryptic proteolysis, and by phospholipids.
    Orellana O; Jedlicki E; Allende CC; Allende JE
    Arch Biochem Biophys; 1984 Jun; 231(2):345-54. PubMed ID: 6329099
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Drug-protein interactions: isolation and characterization of covalent adducts of phenoxybenzamine and calmodulin.
    Lukas TJ; Marshak DR; Watterson DM
    Biochemistry; 1985 Jan; 24(1):151-7. PubMed ID: 3994963
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Calmodulin, activated cyclic nucleotide phosphodiesterase, microtubules, and vinca alkaloids.
    Watanabe K; West WL
    Fed Proc; 1982 May; 41(7):2292-9. PubMed ID: 6122611
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inhibition of Ca2+-dependent protein kinase and Ca2+/Mg2+-ATPase in cardiac sarcolemma by the anti-calmodulin drug calmidazolium.
    Lamers JM; Stinis JT
    Cell Calcium; 1983 Oct; 4(4):281-94. PubMed ID: 6139171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.